Daslemia 100mg Tablet

Name: Daslemia 100mg Tablet
Brand: DRUGS AND DEVICES PHARMA PRIVATE LIMITED
Price: 3500 INR
Availability: InStock

Price 3499.0 INR/ Bottle

Get a Price/Quote

MOQ : 5 Pieces

Daslemia 100mg Tablet Specification

Pacakaging (Quantity Per Box)
30 Tablets

Origin of Medicine
India

Indication
Chronic myeloid leukemia (CML), Philadelphia chromosome-positive

Dosage Form
Tablet

Life Span
Check expiry on pack

Packaging Type
Box

Brand Name
Daslemia

Salt Composition
Dasatinib 100 mg

Drug Type
Specific Drug

Ingredients
Daslemia 100 contains Dasatinib 100 mg, a potent targeted tyrosine kinase inhibitor produced by Intas Pharmaceuticals Ltd. It is widely prescribed for the management of Philadelphia chromosome-positive (Ph+) Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL). Daslemia 100 acts by blocking targeted abnormal proteins that signal cancer cells to multiply. Manufactured in WHO-GMP compliant facilities, this product offers high bioequivalence and efficacy. Available in a pack of 30 tablets for international pharma distributors, hospital procurement, and wholesale export supply. Product Features: High efficacy oral targeted therapy formulation. Formulated in compliance with international quality and manufacturing standards. Moisture-sealed packaging to preserve stability and shelf-life. Manufactured by Intas Pharmaceuticals, a global healthcare leader. Applications: First-line treatment for adults with newly diagnosed chronic phase Ph+ CML. Treatment of post-imatinib resistant or intolerant Ph+ CML in adult patients. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Daslemia 100 contains Dasatinib 100 mg, a potent targeted tyrosine kinase inhibitor produced by Intas Pharmaceuticals Ltd. It is widely prescribed for the management of Philadelphia chromosome-positive (Ph+) Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL). Daslemia 100 acts by blocking targeted abnormal proteins that signal cancer cells to multiply. Manufactured in WHO-GMP compliant facilities, this product offers high bioequivalence and efficacy. Available in a pack of 30 tablets for international pharma distributors, hospital procurement, and wholesale export supply. Product Features: High efficacy oral targeted therapy formulation. Formulated in compliance with international quality and manufacturing standards. Moisture-sealed packaging to preserve stability and shelf-life. Manufactured by Intas Pharmaceuticals, a global healthcare leader. Applications: First-line treatment for adults with newly diagnosed chronic phase Ph+ CML. Treatment of post-imatinib resistant or intolerant Ph+ CML in adult patients. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

Physical Form
Tablets

Function
Other

Recommended For
Blood cancer patients

Dosage
As prescribed by physician

Dosage Guidelines
Follow medical advice

Suitable For
Adults

Quantity
30 Tablets Boxes

Storage Instructions
Store in a cool, dry place

Color
White tablet

Box Material
Cardboard

Prescription Required
Yes

Marketed By
Intas Pharmaceuticals

Strength
100 mg

Expiry Status
Stamped on pack

Pack Type
Box

Route of Administration
Oral

Daslemia 100mg Tablet Trade Information

Minimum Order Quantity
5 Pieces

Supply Ability
1000 Pieces Per Month

Delivery Time
1 Week

Daslemia 100mg Tablet About

Discover outstanding efficacy with Daslemia 100mg Tablet - a first-class anti-cancer medication, especially crafted for blood cancer patients. Shop now and experience the peerless benefits of this Tyrosine kinase inhibitor, recommended and trusted by oncology specialists. Each box contains 30 white tablets marketed by Intas Pharmaceuticals and is optimally packaged in durable cardboard for superior quality preservation. Highly recommended for adults diagnosed with Philadelphia chromosome-positive CML, Daslemia's potency guarantees optimum savings on your treatment regimen. Strictly on prescription, always follow your physician's guidance for dosage and storage. Seize excellent health - choose Daslemia for impeccable results!

Superior Therapy for Targeted Blood Cancer Care

Daslemia 100mg Tablet is a peerless oral medication indicated for adults diagnosed with Philadelphia chromosome-positive Chronic Myeloid Leukemia. Known for its outstanding effectiveness, it features Dasatinib as its active ingredient, working as a powerful tyrosine kinase inhibitor. Its usage is strictly as prescribed by your physician, ensuring first-class, targeted therapy. The box of 30 tablets is easy to store, thanks to its robust cardboard packaging, and is designed for optimal patient convenience and reliability.

Strong Export Capability and Market Availability

Daslemia 100mg Tablet proudly originates in India and is distributed globally by trusted suppliers, exporters, and manufacturers. With consistently high supply ability, rapid drop-off times, and competitive asking prices, this product is highly valued in major export markets. Samples are available for evaluation upon request, ensuring a transparent and reliable procurement process. Take advantage of favorable valuation for bulk orders and experience superior service from order to delivery.

FAQ's of Daslemia 100mg Tablet:

Q: How is Daslemia 100mg Tablet administered?

A: Daslemia 100mg Tablet is taken orally, as directed by your physician. Always follow the exact dosage and schedule prescribed to you.

Q: What specific condition is Daslemia 100mg Tablet recommended for?

A: This medication is primarily indicated for adult patients with Philadelphia chromosome-positive Chronic Myeloid Leukemia (CML).

Q: When should I check the expiry date of the tablets?

A: You should always check the expiry status stamped on the pack before starting a new dosage regimen to ensure safety and efficacy.

Q: Where should I store Daslemia 100mg Tablet for best preservation?

A: Store the tablets in a cool, dry place, away from moisture and direct sunlight, in their original cardboard box packaging.

Q: What is the main benefit of using Daslemia 100mg Tablet?

A: Daslemia 100mg offers outstanding and targeted treatment as a tyrosine kinase inhibitor, efficiently managing certain types of blood cancer in eligible adult patients.